Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
79.80    -0.40 (-0.50%)
Bid:
79.80
Ask:
81.60
Spread: 1.80 (2.256%)
Market Cap: £130.83m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Q3 Trading update

9 Nov 2016 07:00

RNS Number : 6789O
Synthomer PLC
09 November 2016
 

 

November 9th 2016

Synthomer plc

Q3 Trading update

Positive performance and Full Year 2016 guidance maintained

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the third quarter ('Q3') ended September 30th, 2016.

Trading

Europe and North America

Europe and North America has continued to trade well, in line with our expectations and consistent with the positive trends experienced through H1 2016. Q3 reported volumes were in line with last year whilst reported unit margins for the quarter were ahead of Q3 2015 and Q2 2016. Accordingly, with the exception of Paper latex, gross margins across all businesses were stronger than last year. This performance reflects the improved trading environment as well as the Group's focus on efficiency, new product initiatives, strengthened procurement function and investment in business development activities.

Asia and Rest of World

Asia and Rest of World has continued to trade in line with our expectations, with the competitive dynamics in our Asian Nitrile business evolving broadly as expected following the introduction of additional industry capacity.

Reported Asian volumes were marginally lower than last year but sequentially higher than Q2 2016, largely driven by increased volumes in the Asian Nitrile business. As expected, the market environment has led to overall unit margins softening from the highs seen in H2 2015 and H1 2016. Whilst the competitive dynamics in our Asian Nitrile business are continuing to evolve, this downward price pressure has not been as marked as the Group experienced in previous years. We continue to expect full year volumes and margins for this business to be similar to FY 2015.

Hexion PAC

The integration of Hexion PAC is well underway and progressing to plan. The underlying annual EBITDA and expected synergies remain unchanged from the guidance given to the market in March 2016.

Foreign currency

The Group has continued to benefit from the translation effect of the ongoing weakness of sterling. Average YTD FX rates are €1.24 and $1.38 which, if unchanged for the remainder of the year, would provide a translational benefit of approximately £10m for the full year.

Financial Position

The Group has generated strong cash flows in Q3, benefitting from Malaysian land sale and South African business sale receipts of £21m and £13m respectively. Net debt has reduced from £215m at 30 June to £159m at 30 September 2016.

The Group balance sheet remains strong with net debt/EBITDA ratio at circa 1.1x.

Outlook

The Board's expectations for Full Year 2016 remain unchanged from the interim results in August. Looking forward, the outlook in 2017 also remains consistent with our previous expectations underpinned by resilient trading in Europe despite a challenging macroeconomic environment, the Asian Nitrile market continuing to evolve broadly in line with our expectations and the ongoing integration of Hexion PAC.

 

Capital Markets Day

Synthomer plc will be hosting a Capital Markets Day for analysts and investors on Thursday December 1st. Senior members of Synthomer's management team will provide an update on strategy as well as present on the Group's two core divisions and R&D and innovation capabilities.

-ENDS-

ENQUIRIES:

Calum MacLean, Chief Executive Officer

Charles Armitstead

Stephen Bennett, Chief Financial Officer

Teneo Blue Rubicon

Tel: + 44 1279 436211

Tel: + 44 207 260 2700

 

 

The Company will hold a conference call for investors and analysts at 0800 GMT today. 

Please dial +44 (0) 808 2370030 entering conference ID: 31555005# to gain access to the call.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBPBLTMBTMBBF
Date   Source Headline
16th Jun 20114:39 pmRNSHolding(s) in Company
16th Jun 20114:37 pmRNSHolding(s) in Company
13th Jun 201111:14 amRNSNotice of EGM
9th Jun 201110:44 amRNSHolding(s) in Company
12th May 20113:51 pmRNSResult of AGM
12th May 20117:00 amRNSInterim Management Statement
4th May 20113:17 pmRNSAnnual Information Update
3rd May 20111:30 pmRNSHolding(s) in Company
28th Apr 201112:28 pmRNSHolding(s) in Company
21st Apr 20113:24 pmRNSDirector/PDMR Shareholding
21st Apr 20113:19 pmRNSDirector/PDMR Shareholding
7th Apr 20113:00 pmRNSHolding(s) in Company
7th Apr 201110:01 amRNSHolding(s) in Company
7th Apr 20119:15 amRNSAnnual Financial Report
31st Mar 20113:48 pmRNSAcquisition
30th Mar 20114:38 pmRNSHolding(s) in Company
18th Mar 20114:28 pmRNSHolding(s) in Company
15th Mar 20111:42 pmRNSHolding(s) in Company
15th Mar 201110:15 amRNSHolding(s) in Company
14th Mar 201111:22 amRNSHolding(s) in Company
14th Mar 201111:20 amRNSEBT Share Purchase
9th Mar 20117:00 amRNSFinal Results
8th Mar 201111:58 amRNSHolding(s) in Company
8th Mar 20119:17 amRNSDirector Declaration
2nd Mar 20114:47 pmRNSHolding(s) in Company
2nd Mar 201110:27 amRNSAcquisition
15th Feb 20119:40 amRNSAcquisition of Polymer Latex
31st Jan 201112:16 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
20th Jan 201111:26 amRNSHolding(s) in Company
20th Jan 201111:24 amRNSHolding(s) in Company
18th Jan 20114:19 pmRNSHolding(s) in Company
18th Jan 20119:58 amRNSResult of Equity Issue
17th Jan 20115:28 pmRNSResult of Equity Issue
14th Jan 20111:21 pmRNSHolding(s) in Company
13th Jan 20114:33 pmPRNCorrection : Disclosure of Short Position
5th Jan 201112:15 pmRNSDirector/PDMR Shareholding
4th Jan 20111:03 pmRNSHolding(s) in Company
30th Dec 201011:31 amRNSResult of EGM
16th Dec 20105:15 pmRNSHolding(s) in Company
16th Dec 20105:13 pmRNSHolding(s) in Company
16th Dec 20105:05 pmRNSHolding(s) in Company
13th Dec 20105:12 pmRNSPublication of Prospectus
13th Dec 20107:00 amRNSAcquisition and Rights Issue
23rd Nov 201011:42 amRNSHolding(s) in Company
11th Nov 20107:00 amRNSInterim Management Statement
16th Sep 20109:37 amRNSHolding(s) in Company
14th Sep 201010:31 amRNSHolding(s) in Company
26th Aug 20105:42 pmRNSAppointment of Senior Independent Director
26th Aug 20107:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.